Approche physiologique de I`insuffisance cardiaque et rôle de Ia

!""#$%&'("&)*+$,$-+./'(0'(12+3*/4*53%'(
%5#0+5./'('6(#7,'(0'(15(38"#+,)*+3'(
9&5365,(:5/6&+'#(
(((((((;3+68(13*'#<(;=>(?@ABC9D>E(;=>(FGH?(
No relationships to disclose

13*/4*53%'(%5#0+5./'(I(08J3+K$3(
§ LE9(G@?G(!"#$%&'()'*&+,"+*-.%*/(,"0123"',"+*-*+45-%',""6*-"(&,"
*&78*#%," .," '4-(+4(-," 7(" .," 97&+:7&" .(" +;(-" +7&.(%'*&4" <"
(&," %&'()'*&+," .(" +;(-" <" .5#%=-,-" #$7>?@A&," .," 8*&%A-,"
6-767-:7&&,##,"*(>"B,'7%&'".,'":''('C"
§ !99MN!O!( G@?P( !" 12" ,'4" (&" '?&.-78," +#%&%/(," +786#,>," /(%"
-5'(#4," .$(&," *#45-*:7&" '4-(+4(-*#," 7(" 97&+:7&&,##," .("
-,86#%''*@,"=,&4-%+(#*%-,"7(".,"#$5D,+:7&".("'*&@C""
EF2"!"E(-76,*&"F7+%,4?"79"2*-.%7#7@?G""
HIH"!"H8,-%+*&"I,*-4"H''7+%*:7&G""
H22J"!"H8,-%+*&"27##,@,"79"2*-.%7#7@?"J7(&.*:7&"
K+K(--*?",4"*#C"E(-"I,*-4"L"MNOM"
P*&+?",4"*#C"LH22"MNOQ"

Dysfonction diastolique
EF ≥ 50 %
Relaxation et
remplissage altérés
IC avec fraction
d’éjection préservée
Dysfonction systolique
EF < 50 %
Contraction
altérée
IC avec fraction
d’éjection réduite
EF: ejection fraction
13*/4*53%'(%5#0+5./'(Q19R(

Dysfonction diastolique
EF ≥ 50 %
Relaxation et
remplissage altérés
IC avec fraction
d’éjection préservée
Dysfonction systolique
EF < 50 %
Contraction
altérée
IC avec fraction
d’éjection réduite
EF: fraction d’éjection
13*/4*53%'(%5#0+5./'(
S
T
!-'('6(*'U'
VVV(V(
9$<$#W+0+68*

EF < 50 %
Contraction altérée
19(5X'% Y#5%K$3(028Z'%K$3(#80/+6'(